TABLE 1.
Parameter | Value for the parameter by strain |
|
---|---|---|
CL Brener (DTU VI) | Nicaragua (DTU I) | |
TcAKR expression (n-fold)a,i | 3.45 ± 0.46 | 1.86 ± 0.51 |
NADPH-dependent enzymatic activity (nmol NADPH/min/mg) | ||
AKRb,i | 365.37 ± 25.64 | 137.31 ± 8.72 |
QORc | 140.92 ± 13.84 | 44.58 ± 7.53 |
Bz reductased,i | 16.01 ± 0.65 | 2.80 ± 0.73 |
NADH-dependent enzymatic activity (nmol NADH/min/mg) | ||
Bz reductasee,i | 19.43 ± 1.44 | 8.24 ± 1.31 |
Bz trypanocidal activity | ||
IC50 (μM)f,i | 10 ± 0.095 | 20.50 ± 0.30 |
ROS (RFU)g | 4.58 ± 0.88 | 3.63 ± 0.22 |
ψmh | 0.28 ± 0.02 | 0.22 ± 0.02 |
Ratio of the densitometric values of TcAKR and TcCyp19 bands obtained in Western blot assays as shown in Fig. 2B.
AKR activity using 4-NBA as a substrate.
QOR activity using 9,10-PQ as a substrate.
Bz reduction using NADPH as a cofactor.
Bz reduction using NADH as a cofactor.
IC50s calculated by linear regression analysis of the plot of the growth constant versus drug concentration (Fig. 2A).
Detection of intracellular ROS production by flow cytometry using the H2DCF-DA probe of Bz-treated epimastigotes. Values correspond to the relative fluorescence units (RFU) calculated as the median fluorescence intensity (MFI) of Bz-treated parasites/MFI of untreated parasites.
Measurement of change in mitochondrial membrane potential (ΔΨm) by flow cytometry using rhodamine 123 of Bz-treated epimastigotes. Values correspond to the relative fluorescence units (RFU) calculated as the median fluorescence intensity (MFI) of Bz-treated parasites/MFI of untreated parasites.
P < 0.05%, for the difference between results with CL Brener and Nicaragua.